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Abstract
The human papillomavirus (HPV) is a worldwide condition that produces several
diseases, including cervical, anogenital, and oral cancer, among others (Fishman et al., 2014).
The Center for Disease Control and Prevention (CDC; 2016a) stated that HPV is among the most
reported sexually transmitted diseases in the United States. Over 150 viruses are associated with
HPV, and 40 types of the virus can be spread via sexual contact, including vaginal, oral, and anal
sex (CDC, 2016; CDC, 2016b; CDC, 2016c). Evidence shows that approximately 79 million
individuals are infected in the United States, and 14 million Americans are infected with the
virus each year (CDC, 2016c). While the HPV vaccine has been proven to reduce an individual’s
risk of contracting the virus, the number of vaccines administered in the United States has
remained considerably lower than the goal percentage for vaccination of those eligible (Printz,
2015). This evidence-based practice change project aimed to design and offer an evidence-based
educational program to encourage caregivers of children ages 9–17 to approve of the HPV
vaccine for their children. The study explores the impact of the educational intervention program
on improving caregiver knowledge, intentions, and attitude regarding HPV and the HPV vaccine.
Keywords: Human Papillomavirus; HPV vaccine; HPV parents’ education, knowledge,
and attitude and intention; HPV vaccine rates; and HPV-vaccination administration.
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Chapter I: Introduction and Problem Statement of Interest
The human papillomavirus (HPV) is a worldwide condition that produces several
diseases, including cervical, anogenital, and oral cancer, among others (Fishman et al., 2014).
The Center for Disease Control and Prevention (CDC; 2016a) stated that HPV is among the most
reported sexually transmitted diseases in the United States. Over 150 viruses are associated with
HPV, and 40 types of the virus can be spread via sexual contact, including vaginal, oral, and anal
sex (CDC, 2016; CDC, 2016b; CDC, 2016c). Evidence shows that approximately 79 million
individuals are infected in the United States, and 14 million Americans are infected with the
virus each year (CDC, 2016c).
Before the HPV vaccine was introduced, the United States spent approximately $8 billion
each year preventing and treating HPV-associated diseases (Markowitz et al., 2014). Between
2010 and 2015, an average of 48,356 HPV-related cancer cases were diagnosed—24,000 among
females and 14,821 among men—and 88% of these cases were related to HPV infections (Vien
et al., 2016). The vaccine has been found to be a cost-effective preventive measure (Markowitz
et al., 2014). The rate of HPV infections, cervical cancer, oral cancer, anal cancer, and vaginal
warts can be lowered by increasing HPV immunization rates (CDC, 2013; CDC, 2016).
HPV-related infections are more prominent among females than males due to the vagina,
vulva, and cervix, which are the primary cancer sites. Caregivers of adolescent girls may be more
concerned with HPV vaccines than those of boys. Because older teenagers seem to be more like
to engage in sexual activity, it is vital they are vaccinated prior to their initial sexual encounters.
Consequently, it is crucial that caregivers support HPV education to assure their children
recognize the importance of avoiding successive HPV-associated diseases (CDC, 2013; CDC,
2016b).
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To address HPV-related diseases, the U.S. Food and Drug Administration (FDA)
approved the HPV vaccination for children in 2006, which has proven efficacious in preventing
HPV-related cervical, anal, and oropharyngeal cancers, including genital warts (Markowitz et al.,
2014). The CDC recommended that children younger than 15 need two doses of the HPV
vaccine, administered 6–12 months apart (CDC, 2013; CDC, 2016a, CDC, 2016d); those who
receive their doses less than 5 months apart will need a third dose of the vaccine. The
recommended dosage for individuals 15–26 is three doses within 6 months (CDC, 2015; CDC,
2016a; CDC, 2016d). Three doses are also recommended for immunocompromised individuals
ages 9–26 (CDC, 2014; CDC, 2016a; CDC, 2016d). The Advisory Committee on Immunization
Practices (ACIP) recommends that children begin routine HPV vaccination at the age of 11 or 12
because of the morbidity and mortality of HPV-related diseases (Markowitz et al., 2015).
According to a 2015 CDC report, roughly 63% of teen females and 50% of teen males
received at least one dose of the HPV vaccination in 2014; however, the Healthy People 2020
goal for HPV vaccinations was 80% for those eligible. Further, the ACIP recommends routine
HPV vaccines for children, but the immunization rate among adolescents ages 9–17 is lower than
average (Markowitz et al., 2014). Several variables affecting HPV vaccinations among this age
bracket exist, such as a lack of parental awareness or concern for vaccine safety, including low
intent to vaccination; poor attitude toward the vaccine; inadequate provider knowledge; and other
cultural issues (Brabins et al., 2006).
Brabins et al. (2006) reported that several parents or guardians have insufficient
knowledge about the HPV vaccine. Instead, most parents are worried about sexual health
problems that could occur as a component of an HPV vaccination program. Furthermore, some
caregivers object to HPV vaccinations because of (a) the belief that HPV vaccination promotes
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sexual activity, (b) uneasiness concerning the safety of the vaccine and traditional religious and
cultural principles, (c) the possibility of risks from unknown harmful side effects, and (d) a lack
of disease-specific knowledge (Gamble et al., 2010). Many parents or guardians also believe
their adolescents do not need the vaccine because their children are not yet sexually active
(Thomas et al., 2015; Walhart, 2012).
Parental views toward the HPV vaccine must be considered (Gamble et al., 2010). In the
United States, children require parental consent to receive any immunization, but the burden and
healthcare expenditures of HPV-related cancers and diseases remain a crucial public health
problem (English et al., 2008). Therefore, an improved immunization rate is crucial to lessening
the burden of infections caused by the virus.
Background Information
In 2006, the FDA announced that Gardasil, a new HPV vaccine, was authorized for use in
the United States to prevent four types of HPV, various cancers (i.e., cervical, vulvar, vaginal,
oral, and anal), and genital warts (U.S. FDA, 2006). In spite of the efficacy and accessibility of
the HPV vaccination, the number of vaccines administered in the United States has remained
considerably lower than the goal percentage for vaccination of those eligible (Printz, 2015), and
its vaccination rates are lower than countries of similar development. The United Kingdom and
Australia have adopted a system where HPV vaccines are administered through the school
system, resulting in rates of roughly 80%–90% (Printz, 2015). Despite the vast HPV cancerassociated data and the ACIP recommendations, the percentages of the HPV vaccine continued
to be the lowest of all childhood immunizations in the United States (Hughes et al., 2011). In
2009, the vaccine Cervarix was approved to prevent two forms of the HPV viruses, including
those accountable for precancerous lesions and cervical cancer (U.S. FDA, 2009).
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Significance of Clinical Problem
Strategies to promote health and risk reduction can improve adolescent and young adult
developmental factors and decrease their risks for adult-related diseases. Thus, prompt
intervention approaches can help reduce HPV and its related burdens among adults. The primary
approach to encourage vaccine uptake among teenagers is HPV education; however, this
information should come from parents or guardians. In conjunction with the various factors that
affect a youth’s receipt of the HPV vaccine, caregiver awareness is crucial (Gamble et al., 2010);
thus, enhanced vaccine awareness may improve the degree of consent, decreasing a youth’s
susceptibility to HPV.
Previous studies endeavored to explain the facets affecting parental knowledge of HPV;
however, most of these studies are relatively reduced in scope (Jurua et al., 2007). Seemingly, no
research has examined the level of need for parental awareness, intent, and attitude regarding
HPV vaccines. Most importantly, healthcare practitioners must accentuate the HPV vaccine’s
value in lessening cancer in lieu of concentrating on future sexual behavior.
This evidence-based practice (EBP) change project has significant medical inferences
that may improve prospects for caregiver knowledge regarding HPV vaccines. It ascertained
whether parents or guardians can be more vigilant of their child’s health if they become
progressively more cognizant of HPV infections and their implications. Healthcare practitioners
have an essential responsibility of advising caregivers about the HPV vaccine, through which
they can promote vaccine adoption among significantly vulnerable groups.
PICO Question
Variables of the PICO Question
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The PICO question helps limit the literature search for articles and identify questions
informing current practices to improve patient outcomes (Greenlend et al., 2017). The PICO
format presents an outline for addressing evidence-based projects. Four variables address the
PICO question in evidence-based projects: population (P), intervention (I), comparison group
(C), and outcomes measured (O).
Question Guiding Inquiry (PICO)
The PICO question guiding this inquiry is, “For parents or guardians of adolescents ages
9–17, does an educational program conducted at a pediatric clinic wellness visit improve parental
knowledge and attitude toward the HPV and HPV vaccine and improve vaccination uptake in
adolescents?” Several elements have been identified as barriers to HPV vaccinations among
adolescents 9 to 17 years of age: a lack of parental knowledge regarding HPV or concern for
vaccine safety, including low intent to vaccinate; parental attitude toward the vaccine, access to
care, health insurance, and other cultural issues (Brabins et al., 2016).
Population
The target population was parents or guardians of children ages 9–17.
Intervention
The intervention for this research was an HPV and HPV vaccination educational program
using a PowerPoint presentation, a factsheet, a pamphlet, and printed materials.
Comparison
The comparison data used a pre and posttest survey to measure if the intervention affects
caregiver knowledge and attitude toward HPV and HPV vaccine and intent to vaccinate their
children.
Outcome
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The desired outcome consisted of improved caregiver knowledge regarding HPV and
HPV vaccine, attitude toward HPV and HPV vaccine by parents or guardians, intent to vaccinate
their children, and actual and planned vaccination rates for those who receive the intervention.
Cultural competency, community norms, and parent or guardian engagement were also assessed.
Summary
HPV-related diseases are common in the United States, and HPV is the most common
sexually transmitted disease. The tool to target HPV is to educate parents or guardians on the
safety and efficacy of the HPV vaccine for preventing HPV-associated diseases. Education is
critical to increasing a parent or guardian’s decision to consent to the vaccine for their child.
Therefore, the educational program will occur at a pediatric clinic within a family clinic in East
Las Vegas, Nevada, over a period of 6 weeks. This approach will help improve caregiver
knowledge and attitude toward HPV and the HPV vaccine as well as their intent to vaccinate
their children. This EBP project is focused on parents or guardians because parental consent is
required for childhood immunization in most states. Therefore, educating parents should increase
HPV vaccination adoption.
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Chapter II: Review of the Literature
Background
HPV is a global sexually transmitted infection, and the HPV infection rates among
sexually active females range from 20 to 80%, with over 6 million new infections annually and a
90% rate of cervical carcinogenesis associated with HPV infection (Drewry et al., 2010).
Adolescents represent approximately 25% of the sexually active population with a 50% greater
incidence of HPV exposure, which may be related to biological causes, sexual conduct, and
cultural habits, among others (Walhart, 2012).
HPV is a small, capsid, non-enveloped double-stranded epitheliotropic DNA virus that
contaminates epithelial cells (CDC, 2016c); it includes more than 200 strains of viruses that
infect females and males equally (Elmi et al., 2017). These viruses are located on the surface of
the vagina, vulva, cervix, anus, inside the mouth and throat, and genital regions (Vien et al.,
2016). Researchers have identified four main types of HPV and grouped them by their position
in the pathogenesis of epithelial cancer cells as non-oncologic low-risk type or high-risk
oncologic type. HPV 6 and 11 are deemed low-risk types, responsible for roughly 90% of HPV
infections; 16, 18, and genital warts are considered high-risk types, responsible for nearly 70% of
cervical cancers (Vien et al., 2016). Additionally, other strains of the virus are responsible for
different HPV-associated diseases and cancers.
While the likelihood of an individual contracting an HPV virus is high, the HPV
vaccine—the primary treatment for preventing HPV and HPV-related cancers—is an effective
and safe treatment that precludes the highest-risk HPV types. Administration of the vaccine to
adolescents requires parental approval, giving caregivers an important role in the decisionmaking process concerning their adolescents’ HPV vaccine administration and adherence.
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Approaches to enhance parent or guardian awareness about the vaccine include well-developed
educational programs on HPV and the importance of the HPV vaccination for preventing HPV
infections and HPV-associated diseases. The literature showed that an educational intervention
increases caregivers’ knowledge and intent to vaccinate and improves their attitudes toward HPV
and the HPV vaccine (Awadh et al., 2014; Kepka et al., 2011; Reiter et al., 2011; Spleen et al.,
2012).
Sampling Strategies
A comprehensive literature search was done to answer the question, “For parents or
guardians of adolescents ages 9–17 years, does an educational program conducted at a pediatric
clinic wellness visit improve parental knowledge and attitude toward HPV and the HPV vaccine
and increase vaccination rates in adolescents?” The research findings were retrieved through a
comprehensive literature search using the following databases: Embase, COCHRANE Central
register of controlled trials, Medical Literature Analysis and Retrieval System Online
(MEDLINE), and Cumulative Index to Nursing and Allied Health Literature (CINAHL). The
search phrases consisted of “adolescents,” “Human Papillomavirus,” “HPV vaccine,” “HPV,”
“parents’ education,” “knowledge, and attitude and intention,” “HPV vaccine rates,” and “HPVvaccination administration.” The search was limited to free full-text articles and abstracts in
English that were published in the past five to ten years. Inclusion criteria were studies related to
improving HPV vaccine uptake among adolescents and caregiver reasons for not vaccinating
their adolescents with the HPV vaccine. Exclusion criteria involved studies that did not relate to
adolescents. The chosen articles indicated strong support for the EBP change project.
The literature on HPV vaccination supported the belief that caregiver education increases
their knowledge of the HPV vaccine, improves their attitudes about the vaccine, and enhances

8

their willingness to vaccinate their adolescents (Chan et al., 2015; Jurua et al., 2007; Li et al.,
2015). Aside from direct training, effective interventions include an HPV factsheet, PowerPoint
presentation, pamphlets, telemedicine information, and virtual education (i.e., web-based, video,
and telephone seminars and conferences; Awadh et al., 2014; Kepka et al., 2011; Reiter et al.,
2011; Spleen et al., 2012).
The literature review revealed key considerations for this EBP. First, there are several
reasons parents or guardians choose not to consent to the HPV vaccine for their adolescents,
including inadequate knowledge, questions concerning the safety of the vaccine, and the belief
that their adolescents are not engaging in sexual activity. Second, the review indicated that
schools are a good site to offer HPV and HPV vaccine education to parents or guardians of
adolescents.
Reasons Adolescents Are Not Vaccinated Against HPV
There are several reasons parents or guardians are hesitant to allow their adolescents to
receive the vaccine. Reasons include lack of education, vaccine safety, and fear of side effects.
Several caregivers are not well-educated regarding the vaccination, particularly for male
adolescents.
Lack of Education
Many caregivers and adolescents receive little to no information about HPV and the
vaccination; thus, they have insufficient knowledge to make an informed decision regarding the
vaccine (Read et al., 2010; Hughes et al., 2011; Sotiriadis et al., 2012). A study was conducted
by Bair et al. (2008) to assess Hispanic mothers’ knowledge regarding HPV and the vaccine.
Forty mothers with daughters ages 7–14 were interviewed at a pediatric facility in an urban area;
78% of these mothers were unaware of HPV, and 68% were unaware of cervical cancer.
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Following the education, 80% of the participants said they would give consent for their
adolescents to obtain the vaccine. Eight participants disagreed and wanted additional data on the
vaccine or believed their adolescents were too young to receive the vaccine.
Kepka et al. (2014) performed a study that observed the effectiveness of the Spanish
radionovela, a frequently used educational program, for promoting HPV vaccine knowledge. The
Spanish radionovela focused on HPV vaccination knowledge among Hispanic parents or
guardians of adolescents 8–17 years old. The participants were randomly selected to participate
in the HPV vaccination radionovela educational program or an alternative community HPV
program; all participants completed pre and posttest questionnaires. The participants that listened
to the educational program (intervention group) scored higher on knowledge and attitude
questions. The intervention group confirmed that HPV is a common infection (70% vs. 48%, p =
.002); however, they questioned the notion that females could easily contract HPV (52% vs.
31%, p = .003). The sample helped in understanding vaccination age recommendations (87% vs.
68%, p = 003) and confirmed the availability of multiple doses (48% vs. 26%, p = .03). These
numbers were based on comparisons with control group parents. The study revealed that
radionovela health education increased HPV and HPV vaccination knowledge in Spanish
parents.
Spleen et al. (2012) conducted a community-based educational study developed to
enhance HPV-associated knowledge and consent for HPV vaccine administration to ageappropriate girls within the Appalachian area of Pennsylvania. This region had a high rate of
cervical cancer incidence and mortality (Spleen et al., 2012). The program was carried out using
a pretest and posttest questionnaire. The study assessed changes in participants’ knowledge and
awareness of HPV and its vaccine and their decision to obtain the vaccine (Spleen et al., 2012).
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The sample had a total of 117 participants, with 38 (32.5%) being parents of vaccine-eligible
girls and 79 (67.5%) being non-parent guardians (Spleen et al., 2012). The number of parents
with HPV-related knowledge was significant overall (p < .0001) and among parents (p < .0001)
postintervention. The decision to vaccinate adolescent girls within 30 days improved among
parents (p = .0002; Spleen et al., 2012). Of the nine parents (23.7%) that completed the
postintervention interview, 100% indicated the program was beneficial, and 44% stated they had
begun the vaccine series (Spleen et al., 2012). The study revealed that educational intervention
enhanced caregiver awareness about HPV and the HPV vaccination and intent to immunize
adolescents against HPV.
Mupandawana & Cross (2016) conducted a descriptive qualitative study to assess
understanding about HPV infections and the HPV vaccine as well as factors affecting UK-based
African parents’ decision to give or deny consent for the HPV vaccine. Five African parents with
daughters ages 8–14 years were interviewed face-to-face to assess their knowledge about HPV
infections and the HPV vaccine, understanding of cervical cancer, views of the proper age to
receive the vaccine, and partner’s views about the vaccine. The results revealed that parental
knowledge about HPV and cervical cancer was largely low, and caregivers had low-risk opinions
about HPV and HPV vaccination, which led to HPV risk rejection. The results showed the
importance of HPV education for increasing understanding and improving HPV vaccination
rates.
A qualitative study was conducted by Westrick et al. (2017) to assess parent or guardian
knowledge and attitude about HPV vaccines. Twenty-six parents of adolescents ages 11–17 in
Macon or Lee County, Alabama, were interviewed face-to-face (15) or via telephone (11) to
assess their knowledge and opinions about the HPV vaccine. Additionally, caregivers were given
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educational materials on HPV and the HPV vaccination obtained from the CDC, then asked their
thoughts concerning the information they received. The interviews lasted 18–30 minutes. The
findings showed that a lack of complete or accurate knowledge regarding the HPV vaccination is
a significant and frequent factor impeding HPV vaccination acceptance. The findings also
revealed that favorable opinions about the vaccine, coupled with the effect of a highly regarded
source of HPV data, were the two highest-stated factors that support HPV vaccination
acceptance.
Bernard et al. (2011) investigated fear, reactions related to fear, and factors provoking
fear in young girls about to obtain the HPV vaccine in New South Wales, Australia. Participants
12–16 years of age from nine different schools were observed either on the days they received
the vaccine at school or through group interviews. Three answers about fear were documented:
fear of vaccine content and possible side effects, fear of having needles penetrate the skin, and
fear of pain. The results revealed that the girls’ fear responses worsened their peers’ responses,
the lack of privacy made fear worse, and girls experienced more stress while waiting in larger
groups with mates. The findings also indicated that many of the girls had little knowledge
regarding HPV and why they received the vaccine. The inaccurate formation that most of the
girls obtained regarding the vaccine were rumors from family and friends. The three-dose HPV
vaccine rate ranged from 64% to 90% among girls from the nine schools.
Cates et al. (2012) performed a two-part qualitative research study on African American
caregivers of 11–12-year-old boys in North Carolina in which they created messages
encouraging caregivers to allow their sons to receive the HPV vaccine. The initial stage of the
research recruited parents or guardians of this age group to participate in a focus group. Twentynine participants were recruited from local churches and a middle school, 76% of whom were
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female. The findings revealed that participants were uneducated regarding the HPV infection.
Nearly all participants were unaware that HPV can carry dangerous health consequences on
boys. Several participants thought HPV only affected girls and were astonished that the HPV
vaccine is also recommended for adolescent boys in the same manner as adolescent girls. In the
second stage of the research, 100 participants were interviewed in a pediatric office, 75% of
whom were female guardians. Findings from the interviews revealed that roughly 11% of
participants knew the HPV vaccination was recommended for adolescent boys.
Fear of Side Effects and Vaccine Safety
Vaccine safety and effectiveness are among the major reported reasons parents or
guardians reject the HPV vaccination (Gilkey et al., 2012). Dempsey et al. (2009) conducted a
study in Michigan with 52 mothers of daughters ages 11–17. The participants were surveyed via
telephone and asked whether they consented to or refused the HPV vaccine for their girls. Thirtythree mothers consented for their daughter to receive the vaccine; 19 refused. Those who refused
expressed concern regarding the vaccine safety. Additionally, the participants believed their
daughters were at minimal risk for contracting HPV or were not old enough to obtain the
vaccine.
Another reason parents or guardians frequently cited for vaccine refusal was a concern
for adverse reactions that the vaccine may have (Bernard et al., 2011; Kester et al., 2012).
Sortiriadis et al. (2012) conducted a study in Greece with 5,249 female parents or guardians of
adolescents 13 years of age. The women completed a survey to determine the reasons
influencing women’s acceptance of the vaccine for their children and themselves. The
acceptance rate of vaccinating their sons was 77.5% and 78.3% for their daughters. The most
frequent reasons reported by mothers regarding vaccine refusal were a concern for side effects
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and an inadequate understanding regarding the HPV vaccine. The intent to vaccinate their
adolescents declined appreciably after the vaccine became accessible in Greece, and it
corresponded with an increase in women who were worried about adverse events related to the
vaccine.
Lu et al. (2011) conducted a systematic review and metanalysis about the efficacy and
safety of the HPV vaccine. The findings revealed that the vaccine effectively prevents HPV
infections and related precancerous lesions. Systemic and local side effects were essentially mild.
Parents Believe Their Children Are Not Sexually Active
The CDC (2011b) reported that the best age for children to obtain the HPV vaccination is
between 9 and 12 to provide coverage prior to their initial sexual activity. Several parents
postpone HPV vaccine consent for their children because they do not believe their adolescents
are sexually active when most of the time they are (Bair et al., 2008; Dempsey et al., 2009;
Dorrell et al., 2009; Hughes et al., 2011).
Read et al. (2010) administered a survey to caregivers and their daughters in a healthcare
clinic to measure knowledge and attitudes toward HPV and its vaccine. The participants were
girls, primarily African American or of Caribbean descent. The results showed early sexual
introduction by the girls. Forty-nine percent of 175 girls 13–19 years of age stated they actively
engaged in sexual activity at an average age of 14 years. More than 50% of participants reported
having multiple sexual partners. Additionally, 55.8% of girls reported having prior knowledge
about HPV infections. Nearly 39% of 72 parents stated they were undecided whether to
vaccinate their daughters, and 23.6% reported they would decline the vaccine for their daughters.
Lack of knowledge about the vaccine was reported as the most general cause of parents’
rejection of the vaccine.
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Synthesis of the Evidence
Most of the reviewed studies were qualitative in design, which is regarded as a lower
level of evidence reported by Newhouse et al. (2007). Nonetheless, qualitative studies are
appropriate for answering the question, “For parents or guardians of adolescents ages 9–17 years,
does an educational program conducted at a pediatric clinic wellness visit improve knowledge
and attitude toward the HPV and HPV vaccine and increase vaccination rates in adolescents?”
Two limitations were noted among the studies. The first limitation noted the use of convenience
samples in several studies. Second, not generalizable across the United States because the studies
were either completed in a small area of the United States or another country. Despite these
limitations, the literature review offers numerous avenues for healthcare providers to educate
caregivers and adolescents to improve knowledge regarding HPV and the HPV vaccination,
thereby increasing vaccine administrations among adolescent populations.
Healthcare Provider Role
Healthcare providers must put great emphasis on improving health education regarding
HPV and the vaccine for adolescents and parents equally. Studies have shown that parent or
guardian education—or lack thereof—remains the main reason HPV vaccine rates are lower than
recommended. Adolescents and parents, especially those of male adolescents, must be informed
that their sons need the HPV vaccine because several parents or guardians are unaware that the
HPV vaccine is recommended for male and female adolescents. HPV education to caregivers and
adolescents should include information concerning safety and common adverse reactions to the
vaccine.
Barriers to Vaccinate
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The literature review found several barriers associated with adolescents receiving the
HPV vaccine, particularly girls. Barriers for girls include pain at the injection side, fear of a
needle piercing their skin, safety, and vaccine side effects. Both adolescents and parents have
reported these concerns. A barrier for parents is the perceived lack of necessity for the vaccine,
believing their adolescents are not engaging in sexual activity, even if the opposite is true.
Needs Assessment
The clinical director of a family clinic in Southern Nevada was interviewed by the Doctor
of Nursing Practice (DNP) student exploring the EBP change project ideas associated with HPV
vaccination rates and parents’ education. After the interview with the clinical director, it was
clear that there was a great demand to educate parents or guardians on HPV infections and
vaccinations in that community. Ninety percent of patients in the clinic are minorities, and a
large percentage are homeless. The site has partnered with the state to provide immunizations to
children in that community, including the HPV vaccine; however, the staff has not had time to
educate parents. As a result, very few doses have been administered.
The clinical director disclosed that she believed parents at all three clinic sites lacked
knowledge regarding HPV and its vaccine. She also reported that she would like to offer more
educational information to caregivers and their children on HPV and the vaccine, but she has not
had time.
A thorough assessment of the problem was completed with the clinical director in a
family clinic, and it was decided that an HPV educational practice change program was
warranted for parents of adolescent patients in the pediatric clinic.
Mission Statement
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HPV vaccination rates are lower than the Healthy People 2030 target of 80% (Healthy
People, 2021). Family and patient education are linked to improved acceptance of the vaccine.
Nevertheless, despite the accessibility of parental educational materials and social media
communication, vaccine uptake remains below the target goal. Therefore, this project aims to
improve parent and guardian knowledge regarding HPV infections and vaccination through
education, increasing HPV vaccine adoption for adolescents to reach the Healthy People 2030
goal for eligible adolescents in that community.
Goal and Objectives
This project’s goals were to increase parent or guardian knowledge regarding HPV and
HPV vaccination and improve the number of parents or guardians who intend to vaccinate their
adolescents, thereby enhancing the rate of HPV vaccines administered to the community.
There were two key objectives of this EBP change project. The first objective was to
improve knowledge regarding HPV and the HPV vaccination in parents or guardians of
adolescent patients at the pediatric clinic where the study occurred. The second objective was to
enhance attitudes toward the vaccine and the number of parents or guardians who consent to the
HPV vaccine for their adolescents.
Summary
The reviewed literature showed that improving parent or guardian knowledge about HPV
positively influenced attitudes toward the HPV vaccine and their intent to vaccinate (Awadh et
al., 2014; Kepka et al., 2011; Reiter et al., 2011; Spleen et al., 2012; Chan et al., 2015; Jurua et
al., 2007; Li et al., 2015; Middleman and Tung, 2011). Thus, implementing this EBP change
educational intervention will improve parental knowledge and attitude concerning HPV and its
vaccine, increasing their intent to vaccinate their adolescents.
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Chapter III: Theory for Evidence-Based Practice
The goal of evidence-based practice is to utilize great quality, accessible evidence and theoretical
models to guide best medical decisions to improve patients’ health outcome. This EBP change
project aimed to offer an educational intervention program for parents or guardians of
adolescents ages 9–17 to enhance their knowledge about HPV and the HPV vaccine, improve
their attitudes regarding the vaccine, and increase their willingness to consent to the vaccine for
their children. Targeting these areas will likely lead to more adolescents receiving the HPV
vaccine, reducing the rate of diseases and cancers associated with HPV infections (Markowitz et
al., 2015). This chapter introduces the theoretical model used to develop and implement this
project.
Theoretical Framework
The theoretical framework guiding this EBP change project is the Health Belief Model
(HBM). This model (Appendix A) is comprised of six concepts that “influence individual’s
decisions about whether to take steps to prevent, screen for and control condition or illness”
(National Cancer Institute [NCI], 2005, p. 13). This model can be used on an evidence-based
intervention to improve parental knowledge about HPV and the HPV vaccine and improve HPV
vaccine uptakes among age-appropriate adolescents.
The HBM comprises several concepts that explain behaviors related to illness prevention,
screening, or management; these include susceptibility, seriousness, cues to action, self-efficacy,
and advantages and barriers to a behavior. The authors stated individuals are more likely to act
on a health choice when all six of the aforementioned concepts are present. Perceived
susceptibility is the primary concept; individuals must recognize that they are prone to
developing the illness. The second concept is perceived seriousness, meaning individuals must
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realize the illness has severe outcomes. The third concept is perceived advantages or benefits, in
which individuals must believe that the actions they take may lessen their vulnerability to an
illness or its seriousness. The fourth concept involves perceived barriers. Individuals must be
aware that the benefits of taking action are greater than the costs of inactivity. The fifth concept
is a cue to action; that is, individuals must be subjected to elements that provoke action. The
sixth and final concept is self-efficacy. Individuals must feel convinced it is in their capacity to
carry out the action successfully. The authors noted that health motivation is key to the HBM,
and it is essential for establishing short and long-term behavior modification approaches (NCI,
2005). If people perceive themselves as vulnerable to a condition or an illness and presume that
the illness can cause possibly grave outcomes, an available course of action may decrease their
vulnerability to and the gravity of the illness, and the expected advantages of taking action offset
the barriers or costs of action, they are more likely to take action to decrease their risk (McEwen
& Wills, 2011).
Theories or conceptual frameworks are valuable because they inform, enrich, and
complement health education and promotion. To provide efficient and lasting change, nursing
professionals need to apply theories into EBP change projects to model change. The theoretical
framework has shown various approaches to confront HPV vaccination challenges in adolescents
from preceding EBP projects. The HBM helped implement approaches needed during the
planned project execution of the educational intervention program that ensured the change
project’s viability.
Plan for Demographic Data Collection
A demographic data sheet (Appendix B) was used to collect information regarding the
participants, including parent race, gender, age, primary language, marital status, level of
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education, income, insurance for the child, and the number of children in the home. The data was
collected using the demographic sheet questionnaire and analyzed as a percentage.
Plan for Data Collection And Measurement
Participants were asked to complete a 20-question survey to measure their knowledge
about the HPV vaccine, intent to vaccinate, and attitude toward HPV and its vaccine. The survey
included nine attitude questions, eight knowledge questions, and two intent questions. The
collected data was reported as a percentage. The DNP student developed the questionnaire
utilizing a “yes,” “no,” and “not sure” answer format relating to the problems of HPV and HPV
vaccination. The pretest and posttest instruments are provided in Appendices C and D,
respectively.
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Chapter IV: Project and Evaluation Plans
In 2013, the HPV vaccine was launched in 57 countries (World Health Organization),
and countries that offer school-based vaccination programs (e.g., Portugal, Great Britain, and
Australia) have reached 80% or more vaccination coverage. The HPV vaccine has been proven
to have significant health benefits; however, U.S. vaccination rates are low. HPV vaccination
rates are much lower than the recommended target, but promoting awareness of the severity and
incidence of HPV infections and cancer as well as the vaccine’s efficacy in preventing these
diseases may improve parental acceptance (Blasi et al., 2015).
Project Purpose
The aim of this EBP change project was to design and offer a plan for the execution of an
evidence-based educational program for parents or guardians that would influence their decisions
to accept the HPV vaccine for their adolescents ages 9–17. The study explored the impact of an
educational intervention on increasing parent and guardian knowledge, intention, and attitude
toward HPV and its vaccine.
Project Management
This EBP change project requires strong leadership skills to lead a productive study
(Melnyk et al., 2016), which includes a well-defined project management plan to attain the goal
of the project (Saunders & Vehviläinen-Julkunen, 2017). This project will focus on parent or
guardian knowledge regarding HPV and vaccine, attitude toward the HPV vaccine, and
intentions to vaccinate. These perspectives will assist in improving caregiver likelihood of
consenting to the vaccine.
Practice Readiness for Change
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Willingness for change is critical to implementing a new EBP change project (Weiner,
2009). The project site is located in a low-income community with a great need for parental
education about HPV. The site’s clinical director expressed great interest in this educational
project, discussed the project during the clinic’s monthly staff meeting, and reported a high level
of awareness and interest among the staff for its implementation. The number of adolescents
without HPV vaccine at this site supports readiness and willingness for the change practice. The
organization saw this EBP change project as an excellent opportunity to provide the needed
educational intervention on HPV and the HPV vaccine to parents or guardians in the community.
Inter-Professional Collaboration
Interdisciplinary collaboration is critical to the EBP change project as every team
member has a role in developing and offering ideas for implementation. The project’s goals can
be developed and implemented via interdisciplinary collaboration, coupled with team
communication (Harris et al., 2011). It is essential to the progress of the project to communicate
the correct information to the appropriate individuals at the right time, thus improving interprofessional relationships among team members (Zwarenstein & Reeves, 2006).
Every team member must understand the purpose and goals of the project. The team members
involve the project implementer (PI), the facility’s clinical director, a registered nurse (RN) staff,
a medical assistant, and a statistician. The PI was responsible for designing the project, managing
the project’s overall activities, delineating tasks, identifying the participant population, recruiting
consenting participants, presenting the educational intervention and pre/posttests, data collection,
and extracting data from the questionnaires into a Microsoft Excel spreadsheet for analysis. The
clinical director was responsible for sending out recruitment letters to potential participants; she
also provided a conference room for the educational sessions and gave the PI access to the
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potential participants. The RN interacted with participants and assisted with recruitment by
randomly identifying participants for the project. The statistician performed statistical analyses.
The medical assistant assisted with project logistics.
Organizational Approval Process
This project received strong support from the facility’s administration and staff, who
agreed that improving parent or guardian knowledge of and attitude toward HPV and its vaccine
was essential to increasing their likelihood to approve of the HPV vaccine for their children. The
facility gave the PI approval to perform the project at the facility, which was confirmed in a letter
of intent from the facility’s administrator.
Use of Information Technology
Companies, organizations, and institutions constantly leverage evidence-based change
projects to ensure they remain relevant and competitive in their respective fields (Too & Weaver,
2014), and effective information technology (IT) was essential to a successful project. For this
project, IT was used to retrieve, collect, and store data during the literature review. The facility
also dedicated a laptop to the PI to prepare flyers and PowerPoint slides and a projector for the
education session. Further, communication among team members was primarily done via email
and phone calls. Of note, the team employed standard safeguards, such as locking cabinets and
using password-protected systems, during data collection to ensure confidentiality and
anonymity of participants.
Materials Needed for Project
The materials needed for this evidence-based change project included a laptop equipped
with Microsoft Excel software, one flash drive, one file cabinet, four file folders, one projector, a
display screen, one ream of 8x10 white and colored printing paper, four packets of ballpoint
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pens, and a color printer and ink cartridges. A conference room was secured within the practice
setting for the educational intervention program.
Institutional Review Board Approval
The University of Nevada, Las Vegas Institutional Review Board approved this EBP
change project.
Project Evaluation
Project evaluation measures the benefits, risks, costs, and uncertainties of decisionmaking by assessing a project’s outcome and how it benefits an organization (Chi et al., 2016).
In evaluating this study, the anticipated project outcomes included increased parental knowledge
on the HPV and HPV vaccine, increased vaccination intention, and improved parental attitude
toward the HPV vaccine.
Evaluation Tool Data
The study by Kepka et al. (2011) was used to benchmark this EBP change project’s
outcomes, including the degree of knowledge improvement, attitude, and intent. This study was
selected because it was randomized, and its sample appeared economically comparable to this
EBP project’s sample group. In their study, Kepka et al. (2011) observed a significant increase in
HPV knowledge for 70% of the intervention group compared to 48% of the control group (p =
.002); the intervention group also demonstrated a significant shift in attitude and belief compared
to the control group, experiencing a change of 53% compared to the control group with 31% (p =
.003). The study by Chan et al. (2015) was used to benchmark intent to vaccinate, in which the
researchers provided an educational intervention to Hispanic adults through a photographic short
story (i.e., fotonovela). Chan et al. (2015) measured participants’ perceived exposure to HPV,
intent to vaccinate, perceived advantage of the vaccine in a committed relationship, intent to
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encourage others to vaccinate, and attitude toward vaccination; they observed an increase in all
five variables post study, with percentage improvements for each as follows:
Perceived susceptibility to HPV (10.5%, p = .25)
Intent to vaccinate (18.4%, p = .06)
Perceived advantage of vaccine (7.8%, p = .25)
Intent to motivate others to vaccinate (10.5%, p = .14)
Attitude toward vaccination (13.1%, p < .05)
Data Analysis
This EBP change project’s primary goal was to analyze the educational intervention’s
effectiveness based on the mean scores of preintervention and postintervention data. The
anticipated outcomes included postintervention scores revealing enhanced knowledge, intent to
vaccinate, and attitude toward the HPV vaccine. The collected data were organized and analyzed
utilizing Microsoft Excel; however, an increase in knowledge on HPV vaccine, vaccination
intentions, and attitude regarding HPV was assessed independently. The paired t-test and
analysis of covariance were used to evaluate change from baseline to post intervention. The
efficacy of the intervention was analyzed using paired t-test with significance. SPSS 24.0 was
used to analyze all demographic and intervention data. The outcome was intended to be reported
as a mean percentage increase in knowledge about the HPV vaccine, intent to vaccinate, and
parental attitude regarding the vaccine.
Data Management
The survey data was transmitted to an external disk drive kept in a secret passwordprotected locked cabinet. The PI was the only person with access to the locked cabinet.
Furthermore, data was backed up on the password-protected hard disks, and Microsoft Excel
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software was used to arrange and analyze data. All data will be stored for up to 5 years to enable
publications or presentations. After this period, all project documents in paper form will be
disposed of in a secure manner and sent to a shredding company for proper disposal; electronic
data will be formatted to thwart future access.
Summary
The fundamental aspect of project management is planning. Through effective planning,
the project team identified and designated tasks to each team member and determined how each
task would be accomplished. A well-organized plan helped optimize project resource use and
reduced the time spent resolving problems during implementation. Informing parents or
guardians to improve their knowledge and attitudes toward the HPV vaccine was essential to
enhancing intentions to vaccinate. This EBP change project used educational approaches to
achieve these objectives.
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Chapter V: Implementation
While HPV causes cervical, penile, oropharyngeal, and anal cancer and warts (CDC,
2017; Lewis et al., 2015), multiple research studies have revealed the significant benefits and
effectiveness of the HPV vaccine in stopping diseases and conditions related to HPV infections
(Lu et al., 2011). The aim of implementing this EBP change project was to provide an
educational intervention for parents or guardians of adolescents ages 9–17 to improve their
knowledge about HPV infections, improve their attitudes about the HPV vaccine, and increase
their responsiveness to accepting the vaccination. The implementation phase of this project
occurred over a period of 8 weeks, including the recruitment and advertisement process.
Setting
The EBP change project took place in a non-profit family practice offering preventive,
primary care, pediatric, dental, and behavioral healthcare services to a low-income community in
southern Nevada. Additional services offered at the facility include social worker assistance, a
support group for young mothers, and community care services for individuals with behavioral
and addiction problems. Over 800 children and adolescents receive primary care at the facility
each month.
Participants
The participants were adult parents or legal guardians of children ages 9–17. There were
no restrictions placed on participants concerning gender, religion, race, or ethnicity. All
participants were fluent in English and able to read and write English. Both parents were
permitted to participate in the educational project; however, only female parents or legal
guardians participated in the educational sessions.
Recruitment
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The front desk medical assistance aided the PI in recruiting participants by handing out
flyers and brochures to parents or guardians when they arrived for scheduled appointments.
Poster boards were also displayed in the waiting room throughout the program. The MA
informed each person who wanted to participate in the educational program to contact the PI via
telephone, text message, or email, which were listed on the flyers and brochures. The PI was
present at the project site during recruitment to explain the educational project to participants and
answer any questions. A cover letter, which disclosed the aim of the project and risks involved,
was provided to participants, and the consent form was signed on the first day of the educational
session. Each participant was given a unique identification code linked to the questionnaire to
ensure participant confidentiality. The recruitment process continued for 8 weeks, until the last
educational session ended, since parents or guardians came to the facility at different times
throughout the day.
Threats and Barriers
Predicted threats and barriers to this project included low interest in the study by
participants, a lack of trust, and low attendance. Another anticipated threat was the facility’s
closure in observance of Christmas Eve and New Year’s Eve, which prolonged recruitment by 2
weeks. Educational session days and times were shifted from what the PI initially scheduled to
accommodate schedules; for instance, several of the educational sessions were conducted in the
mornings and on Saturdays to guarantee accommodation for all participants. There were fewer
participants than expected; this was possibly due to the recruitment window (i.e., holiday season)
and concerns regarding the COVID-19 pandemic. Two participants walked out of the room while
the educational session was in progress to answer telephone calls, but they returned to complete
the session a few minutes later. These participants were given an opportunity to remain at the
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end of the session to review the sections they missed. A few participants also asked for
additional one-on-one sessions to discuss sections of the presentation that were not clear to them;
the PI granted these requests.
The politicization of the COVID-19 vaccine—visible in statements by prominent
politicians, political disagreement in public conversation, and media reporting regarding the
nature of the virus—has undoubtedly caused hesitancy toward vaccines in general. It can be
concluded that the magnitude of political rhetoric and conflicts related to the COVID-19 vaccine
has influenced public trust and reception of vaccines at large.
Data Collection
Project implementation and recruitment began on December 1, 2021. The educational
sessions were presented twice weekly in group and one-on-one presentations for those who could
not participate in group sessions. The PI reviewed the cover letter with participants a second time
and provided them with the consent form at the beginning of the first educational session. After
participants signed the consent and completed the demographic form, the PI administered a
pretest questionnaire to each participant to baseline their knowledge on HPV and the HPV
vaccine. Participants were given 10 minutes to complete the pretest questionnaire, then a 10minute break. The educational session followed, which was completed in groups of three
participants (i.e., parents or guardians). During this potion, participants received a 10-minute
PowerPoint presentation and handout materials regarding HPV and the HPV vaccine. The
participants were then given a 5-minute break post presentation. A posttest questionnaire, which
took about 10 minutes to complete, was administered to participants to assess whether their
knowledge improved from the pretest.
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A total of 12 group educational sessions and three one-on-one sessions were held. Each
group session lasted nearly 1 hour, including the time to complete the questionnaires. Each
participant received a thank you card at the end of each educational session. The PI remained at
the site after each session to answer questions. The data collected from the preintervention and
postintervention tests was entered into Microsoft Excel and analyzed.
After completing the EBP change project, all evaluation tools were stored in a protected
and confidential place for the designated time per IRB and university guidelines, then destroyed.
This educational project was not considered harmful to human subjects because participants were
taught on existing recommendations for age-appropriate adolescent HPV vaccinations endorsed
by the CDC and ACIP. The results of the educational program may be applied in several settings
where vaccinations are provided to children. By effectively informing parents or guardians, this
EBP change project may improve HPV vaccine rates and assist as an improvement project model
that can decrease healthcare spending and promote adolescent and young adult health.
Data Analysis
The data gathered from the pre and posteducational program surveys was evaluated and
analyzed. A paired t-test was used to assess the results of the project to determine if there was a
significant difference in the initial and postintervention results for the three phases of the survey:
knowledge, attitude, and intent to vaccinate. This method provided the findings and impacts of
the educational project and aided in evaluating its effectiveness. The t-test results are as follows:
Knowledge: t is 11.464; p is < .00001. The result is significant at p < .05.
Attitude: t is 22.8495; p is < .00001. The result is significant at p < .05.
Intent to vaccinate: t is 6.708; p is .00001. The result is significant at p < .05.
The significance level for the t-test is 0.05.
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Note: The paired t-tests with the statistically significant results indicate that the intervention was
successful in all three areas of the survey.
Based on the results, the need for future projects on the HPV vaccine is recommended.
Findings and Outcomes
According to Arrossi et al. (2017), the HPV vaccine, coupled with regular cervical cancer
screenings, is the typical method for early detection and prevention of HPV-associated cancers
and diseases. The implementation of this EBP change was conducted to address the problem of
inadequate HPV vaccine uptake among age-appropriate adolescents. This study aimed to
improve parental knowledge, vaccination intention, and attitude toward the HPV vaccine:
centered on a comprehensive literature review, education was shown to be the best approach to
achieving these objectives. This section provides the findings and outcome of the project,
including the relationship between this study and those identified in the literature review, and the
impact of this EBP on nursing practice.
Participant Demographics
Thirty participants were recruited for this EBP change project; however, only 22
participants completed the project for an overall participation rate of 73.3%. All participants
were female, ranging from 24 to 59 years of age, with a mean age of 40.5 years. Regarding race,
72.7% of participants identified as Caucasian, 9.1% Hispanic, and 18.2% African American. Out
of all participants, only one identified as a guardian rather than a mother. Most participants (12;
54.5%) had a high school diploma; however, only one participant (4.5%) had some level of
college education, and 6 (27.3%) only had a grammar school level of education. Three
participants (13.6%) did not identify their education level on their completed questionnaires.
Most participants (16; 72%) were single, 5 (22.7%) were married, and 1 (4.5%) was divorced.

31

The number of children per participant household ranged from 1 to 8 with a mean of 3.5. Family
income varied with 11 participants making less than $20,000 per year, 10 making between
$20,000 and $30,000, and one making between $30,000 and $50,000. The mean household
income using the midpoint of each range was $18,181.82. (See Figure 1).

Figure 1
Participant Demographics

Age Groups
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Outcomes
The analysis was completed based on the 3 specific outcomes assessed during project
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implementation. The expected outcomes for caregiver participants were improved knowledge
about HPV, attitudes toward the HPV vaccine, and intent to vaccinate their adolescents following
the education program.
Outcome One: Increased Knowledge of HPV. A questionnaire was administered to
each participant to assess their knowledge of HPV. A total of 10 items were included on the
questionnaire as an objective measure of parental knowledge regarding the HPV vaccine.
Participant knowledge level was assessed pre and postintervention. The differences in group
cumulative scores were analyzed to assess the overall impact of the education intervention (see
Tables 1 and 2). The individual pretest mean ranged from 0.05 to 0.95 with a group mean of 0.4;
individual posttest means scores ranged from 0.18 to 1 with a group mean posttest of 0.8. The
change in group mean from the pretest and posttest intervention was 100%, which surpassed the
benchmark improvement of 20%. The postintervention standard deviation increased to 0.29 to
0.32, indicating that the variability in knowledge among all the participants’ stayed the same in
both pre- and post-intervention.

Table 1
Group HPV Knowledge Test Scores
Statistics

Pretest

Posttest

Mean

0.4

0.8

Mode

0

1

Median

0

1

0.29

0.32

Standard Deviation

Range
1
Note: Outcomes based on data gathered from Knowledge Questionnaire Survey.
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Table 2
Group Knowledge Preintervention and Postintervention

Preintervention (Left) vs. Postintervention (Right) Knowledge
0.9
0.8
0.7

Mean Score

0.6
0.5
0.4
0.3
0.2
0.1
0
1

2

Outcome Two: Improved Attitude. After the educational intervention, parental
attitudes toward the HPV vaccine improved significantly. The posttest mean score was 0.7
compared to the pretest mean score of 0, represent a significant improvement in attitude
following the education intervention. With a 0, the percent improvement cannot be calculated;
however, an increase from 0 to 0.7 is large enough to meet the benchmark initially set at 20%.
Likewise, the posttest standard deviation increased from 0.03 to 0. 40 (See Tables 3 and 4).
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Table 3
Group Parental Attitudes toward HPV Scores
Statistics

Pretest

Posttest

Mean

0

0.7

Mode

0

1

Median

0

1

0.03

0.4

Standard Deviation

Range
1
Note: Outcomes based on data gathered from Attitude Questionnaire Survey.

Table 4
Group Attitudes Preintervention and Postintervention

Preintervention (Left) vs. Postintervention (Right) Attitudes
0.8
0.7

Mean Scores

0.6
0.5
0.4
0.3
0.2
0.1
0
1

2
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Outcome Three: Intent to Vaccinate. Parent and guardian intent to vaccinate improved
after the education intervention. The group mean score increased to 0.7 from a pretest score of 0,
indicating a significant improvement in the intent to vaccinate among parents or guardians. This
also surpassed the 20% benchmark initially set for improving parental intent to vaccinate
postintervention. (See Tables 5 and 6)

Table 5
Group Parental Intent to Vaccinate Scores
Statistics

Pretest

Posttest

Mean

0

0.7

Mode

0

1

Median

0

1

Standard Deviation

0

0.48

Range
0
1
Note. Outcomes based on data gathered from Intent to Vaccinate Questionnaire Survey.
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Table 6
Group Intent to Vaccinate Preintervention and Postintervention

Preintervention (left) vs. Postintervention Intent to Vaccinate
0.8
0.7

Mean Scores

0.6
0.5
0.4
0.3
0.2
0.1
0
1

2

It can be concluded that improved knowledge, attitude, and intent to vaccinate translated
to increased importance placed on the HPV vaccine by parents or guardians for their adolescents.
The lack of knowledge regarding the vaccine may have been the primary reason for vaccine
refusal. Additionally, it is likely some parents may have been hesitant to consent to the HPV
vaccine for their children because of misconceptions concerning the vaccine’s side effects. These
beliefs can only be eradicated through a thorough educational intervention, which succeeded in
the case of this study.
Addressing the Problem Identified
Fifteen educational sessions were implemented over 8 weeks, using pre and posttest
surveys to determine the effectiveness of educational interventions. Data analysis revealed this

37

project improved parental HPV knowledge, attitude toward the vaccine, and intent to vaccinate.
Thus, educating parents or guardians of adolescents on the HPV vaccine is critical for improving
HPV vaccine acceptance and preventative health for HPV-related cancers and diseases. Insights
from this educational project will assist in enhancing the knowledge of parents or guardians of
adolescents on HPV infection and the vaccine.
Project Monitoring
The DNP student was the PI and was responsible for designing, implementing, and
collecting the data for this study. The project team aided in scheduling participants for
educational sessions, assisting in setting up the designated conference room in the facility, and
supported project delivery. The project team worked closely with the DNP student through the
completion of the project. The DNP student collected recommended evidence-based approach
for parental education on the HPV and the vaccine and developed the EBP change project. The
DNP student launched the educational PowerPoint presentation that focused on evidence-based
interventions for parents or guardians of adolescents and aimed to improve participant
knowledge of the HPV infection, intent to vaccinate, and attitude toward the vaccine. No
incentives were provided for project participation.
Discussion of Project Relationship and Literature Review
Using the education approach to improve the knowledge of parents or guardians of
adolescents not only integrated recommendations for a change in practice learned from current
literature, but it likewise involved theoretical underpinnings from the HBM. The HBM was
designed to identify the failure of individuals to adopt disease prevention approaches or
screening tests for the early detection of diseases (Fishman et al., 2014). Consequently, this
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model was utilized to determine how parental education could affect the decision of parents to
accept the HPV vaccine as a preventive health measure for their adolescent children.
This EBP change project addressed the lack of parental knowledge regarding the HPV
vaccine through education sessions, which used a PowerPoint presentation and handouts; this
method proved to be an effective approach for improving parent and guardian knowledge of the
HPV infection and the vaccine. The findings from this project support previous studies that
revealed an increase in HPV vaccine uptake following parental education (Awadh et al., 2014;
Kapka et al., 2011; Reiter et al., 2011; Spleen et al.; 2012). While current literature shows a lack
of parental knowledge contributes to low vaccination rates, it does not indicate whether parents
or guardians can be effectively educated on the importance of the HPV vaccine for their children
to improve vaccine uptake and adherence (Brabins et al., 2006). This project addressed the
knowledge deficit in the above literature by exploring various methods to improve parental
education, from self-directed computer-based learning to one-on-one sessions to a classroom
setting. The postintervention analysis revealed that the education sessions significantly improved
parental knowledge of HPV and the HPV vaccine, attitude toward HPV, and intent to vaccinate.
Advance or Improve Practice
This EBP change project can be used to improve practice as health care providers and
professionals can design classroom-like educational intervention programs for parents or
guardians of adolescents to improve HPV vaccine acceptance. Nurses can implement similar
educational programs in their practice settings to address low HPV vaccine uptake. However,
addressing inadequate HPV vaccine rates will require effort and determination from the nursing
community. Nurses could also endeavor to initiate discussion of the HPV vaccine at every
clinical encounter. Based on the outcomes of this project, healthcare providers, nurses, and
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public health professionals can effectively educate parents or guardians of adolescents about
HPV and its vaccine. By applying the educational intervention approach of this project to a
clinical setting, medical providers can offer opportunities for parents or guardians to learn more
about the various cancers and diseases associated with HPV and how they can be prevented. This
project could likewise help achieve the Healthy People 2030 goal of fully vaccinating 80% of
adolescents with the HPV vaccine by age 15.
Potential for Sustainability
Improving the health and wellbeing of a population is not a simple task. Addressing
parents or guardians as the focus population for this EBP change project aided in closing the
knowledge gap that existed between the participants in this project. Long-term approaches are
required to sustain change. Healthcare providers, nurses, and other healthcare professionals must
constantly educate parents or guardians of adolescents on outcomes and best practices to address
deficits in parental education, close the knowledge gap, and assist caregivers in making informed
decisions on the administration and adherence of the HPV vaccine for their children (Reiter et
al., 2018). Upon conclusion of this project, several approaches are considered to sustain the
positive changes that were accomplished. These approaches involve the Southern Nevada Health
District, community pediatric clinics, and other community organizations that provide healthcare
services to children to carry out projects emulating this EBP. For instance, plans are in progress
to offer group sessions or one-on-one presentations to doctors and nursing staff in the facility’s
other location to inform clients of the positive impact of the project. The main objective of
meeting with staff is to encourage them to provide parental education on the HPV vaccine
utilizing this project’s approach to maintain sustainability. Additionally, the DNP student plans
to meet with various pediatric offices within the neighborhood to inform them of the
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effectiveness of this project and distribute the PowerPoint and handouts used for this project,
which will likewise facilitate sustainability.
The DNP student has incorporated a sustainability plan at clinics where the project
occurred to continue improving HPV vaccine knowledge and reception. Several approaches have
been considered beneficial for maintaining the positive changes achieved through his project,
including developing an educational toolkit to increase HPV and HPV vaccine awareness for
parents and guardians of adolescents 9–17 years of age. The toolkit will include credible
websites that provide HPV and HPV vaccine information to improve parents’ awareness.
Additionally, copies of the PowerPoint presentation and other handouts were printed and placed
in the waiting room for parents to read while waiting for scheduled appointments. These
handouts were also placed in each examination room for providers to hand out when discussing
immunizations with parents or guardians.
Future Scholarly Work
Recommendations for future scholarly work based on this EBP change project are
numerous and varied. One suggestion is to educate parents or guardians of adolescent children
on the importance of HPV and the HPV vaccine, analyze pre and postintervention data, and track
HPV vaccine rates at the facility where the project took place. Adolescents should also be
included in these educational sessions because they need to be informed regarding HPV
infections and the vaccine as much as the parents and guardians (Brabins et al., 2006). Future
projects should be offered several facilities rather than just one facility and recruit a greater
number of participants, considering the larger the sample size, the more statistically significant
the p value, making the project finding more valid (Greenlend et al., 2017). Further, future
projects should involve individuals who speak other languages aside from English and provide
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interpretations for various languages such as French and Spanish. Recruiting only parents or
guardians who speak, read, and write English restricts the number of participants reached,
limiting the size as well as the demographic of the community receiving the education
intervention.
Plan for Dissemination
Dissemination of the research is the final phase of a study, which involves distributing
research findings through publications and presenting the findings to various audiences—for
example, participants, nurses and other healthcare professionals, policy developers, and
consumers (Grove & Burns, 2013). The DNP student plans to contact various pediatric offices
within the community to introduce and arrange time to present the project to their management
teams. The DNP student also intends to disseminate the project results at the national level by
applying to present this project at the annual Western Institute of Nursing (WIN) conference in
spring 2022.
Strengths
Addressing the HPV vaccine is well-supported as a crucial health objective, particularly
within the adolescent population. The strengths of this EBP change project included a detailed
evaluation of the current literature on HPV vaccines, which supported the need for further study
because of the limited number of systematic reviews and meta-analyses that exist on the topic of
parental education on the HPV vaccine. There is a great need to build on current studies to define
best practices to surmount the impediments concerning the HPV vaccine. The educational
presentation utilized evidence-based practice recommendations from current literature on
parental communication approaches on the HPV vaccine. Even with the small sample size,
79.09% of the study participants felt the education they received improved their knowledge,
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74.24% had improved attitude toward the vaccine, and 68.18% reported they intend to vaccinate
their children against the HPV virus. Also, the findings suggest that delivery of this project in
other locations, such as health departments, schools, dental offices, and other organizations that
provides children and family services, could also result in improved parent or guardian
knowledge concerning the HPV vaccine.
Limitations
The limitations of this project include its small sample size and short time window for
implementation. The project outcomes may have been different if a larger population had been
recruited. Additionally, a longer study window may have reached a different conclusion.
Summary
The clinical question answered by this EBP project was as follows: “For parents or
guardians of children ages 9–17, does an educational program conducted at a pediatric clinic
wellness visit improve knowledge and attitude toward HPV and the HPV vaccination and
increase vaccination rates in adolescents?” The findings revealed that parental knowledge on
HPV and its vaccine, attitude toward HPV, and intent to vaccinate significantly increased
following the intervention. This project demonstrated that the parental educational intervention
yielded a statistically significant effect on HPV knowledge, including intent to vaccinate.
Furthermore, the intervention increased the possibility that parents or guardians would consent to
the vaccine for their children after completing the intervention. Four weeks postintervention, the
DNP student followed up with the participants and their adolescent children and discovered that
11 out of the 22 (50%) adolescents whose parents participated in the educational program had
received the HPV vaccine at the project site. This result revealed that an evidenced-base parental
educational program increased parent or guardian knowledge of HPV and their intent to
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vaccinate their children. Nurses and other healthcare providers are best positioned to offer
evidence-based education to parents or guardians of adolescents to improve their knowledge
about the HPV vaccine. Together they can increase vaccination rates and achieve the Healthy
People 2030 goal of completely vaccinating 80% of adolescents with the HPV vaccine by the
age of 15, improving population health.
Conclusion
This EBP project was conducted in a low-income community where participants were
engaged with the project, expressing a great desire to learn about HPV infections and the
vaccine. The large percentage of the postintervention mean outcome on all questionnaire surveys
revealed an improvement in participant knowledge, attitude, and intent to vaccinate their children
against HPV infections. This result exceeded the benchmarks set at the start of the project. Plans
are in progress to continue with this project at a broader level to reach the larger area, including
pediatrics offices and community healthcare centers that provide children and family services
within the community. The anticipated outcomes are improved parent or guardian knowledge of
HPV infections and vaccines and improved HPV vaccine administration and adherence.
While the end goal of this EBP change project was to improve HPV vaccination rates to
the recommended target goal of 80%, overall prevention of diseases and cancers is also essential
to consider. Though not part of the project, healthcare providers should also address infertility
related to HPV infection since it is a complex condition affecting an estimated 8–12% of
reproductive-age couples, or 48 million couples globally. A study conducted by Hsu et al. (2020)
revealed a greater risk of female infertility in individuals with prior HPV infection, particularly
those 26–35 years of age. Therefore, discussions about the HPV vaccine as a preventive measure
are paramount to decreasing an individual’s likelihood of contracting HPV.
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Appendix A
Health Belief Model

45

Appendix B
Demographic Form

Demographic Questionnaire
Code Number: ______________
Please answer the following questions as completely as possible. If you do not know the
answer to a question, please leave it blank.
What is your age?
You are the: Mother

Father

Gender: (Please circle one) Male

Guardian
Female

Primary language: (Please circle one) English

Spanish

Arabic

Other

Highest level of parental education obtained: (Please circle one)
Grammar school
High school
College
Some college
Bachelor's degree,
Master's degree
Doctoral degree
Professional degree or certificate
Other.
Yearly household income: (Please circle one) Less than $20,000
$30,000-$50,000
above $50,000.
Insurance Provider: (Please circle one) Public

Private

How do you classify yourself? (Please circle one) Caucasian
Asian / Pacific Islander
Latino
Arab
Multiracial

$20,000-$30,000
Self-Pay
Black
Other.

No insurance
Hispanic

What is your marital status? (Please circle one) Married Divorced Separated Single
Widow
Religion: (Please circle one) Christian Jewish Muslim Atheist Other
How many children do you have?
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No Comment

Appendix C
Knowledge Questionnaire
Pre-Post Questionnaire Knowledge Survey
Code _______________

Dear Participant, please read and circle the most appropriate answer.

1. My child may have HPV and still be unaware. (A) Yes (B) No
2. HPV can be contacted through sexual activities. (A)

(C) Not Sure

Yes (B) No (C) Not Sure

3. Cervical cancer are caused by HPV (A) Yes (B) No (C) Not Sure
4. HPV is spread through (A) skin to skin contact (B) Sexual Act
5. HPV vaccine prevents sexually transmitted infection. (A) Yes (B) No (C) Not Sure
6. The vaccine can prevent cervical cancer or genital warts. (A) Yes (B) No (C) Not Sure
7. HPV vaccine can be given to children ages 9 to 17. (A) Yes (B) No (C) Not Sure
8. HPV vaccine has side effects. (A) Yes (B) No (C) Not Sure
9. HPV infection can cause cancer. (A) Yes (B) No (C) Not Sure
10. The HPV vaccine is a one-time injection for children ages 9-17. (A) Yes (B) No (C) Not Sure

Comment:
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Appendix D
Attitude Questionnaire

Pre-Post Questionnaire Parental Attitude toward HPV Vaccination Survey
Please, circle the correct answer of your choice.
1. It is important to have my child vaccinated with HPV vaccine before being sexually active.
(A) Yes (B) No (C) Not Sure
2. HPV vaccine is good for my child (A) Yes (B) No

(C) Not Sure

3. HPV vaccine was developed because drug companies want to make more money from the
people. (A) Yes (B) No (C) Not Sure
4. Do you think the HPV vaccine is safe for your child? (A) Yes (B) No (C) Not Sure
5. If my child had HPV vaccine, it will be a privilege to engage in sexual activity. (A) Yes (B)
No (C) Not Sure
6. HPV vaccination is forbidden in my religion. (A) Yes (B) No (C) Not Sure
7. HPV vaccine is safe for my child and my child will receive the vaccine (A) Yes (B) No (C)
Not Sure
9. Compliance to HPV vaccine keep my children healthy. (A) Yes (B) No (C) Not Sure
10. Adherence to HPV vaccine schedule is important. (A) Yes (B) No (C) Not Sure

Comment:
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Appendix E
Intent to Vaccinate Questionnaire

Pre-Post Questionnaire Intent to Vaccinate Survey

Code _________________________

Dear Participant, please read and circle the most appropriate answer.

1. My plan is to get my child vaccinated with HPV vaccine. (A) Yes (B) No (C) Not Sure
2. If your child has not received the HPV vaccine, do you intend to have her/him get the
HPV vaccine in the future (A) Yes (B) No (C) Not Sure

Comment:
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Appendix F
Frequency Tables
Table 7
Frequency Table: Knowledge Questionnaires (N = 22)
Answer
Percentage

Preknowledge

Postknowledge

36.40%

79.09%

Table 8
Frequency Table: Attitude Questionnaires (N = 22)
Answer
Percentage

Preattitude

Postattitude

2.02%

74.24%

Table 9
Frequency Table: Intent to Vaccinate Questionnaires (N = 22)
Answer
Percentage

Preintent to Vaccinate

Postintent to Vaccinate

0.00%

68.18%
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A New Day Community Health Care Center
Las Vegas, Nevada
Advance Practice Registered Nurse

March 2016 – March 2017

60

Family Nurse Practitioner
Integrated Medical Group
Las Vegas, Nevada (Mobile-Integrated Care)
Advance Practice Registered Nurse
Family Nurse Practitioner

August 2015 – March 2016

VA Southern Nevada Healthcare System
Las Vegas, Nevada
Registered Nurse
In-patient Mental Health

October 2015 – February 2017

VA Southern Nevada Healthcare System
Las Vegas, Nevada
Registered Nurse,
Acute Rehabilitation

January 2014 – October 2015

VA Southern Nevada Healthcare System
Las Vegas, Nevada
Registered Nurse
Medical Surgical

June 2010 – January 2014

Harmon Medical and Rehabilitation Hospital
Las Vegas, Nevada
Registered Nurse
Medical Surgical

March 3010 – September 2010

CREDENTIALS
The American Academy of Nurse Practitioners (FNP-C)
American Nurses Credentialing Center (FPMHNP-BC)
Advance Practice Registered Nurse (APRN) – Nevada State Board of Nursing
U.S. Department of Justice – Drug Enforcement Administration License
Licensed Prescriber – Nevada State Board of Pharmacy
Registered Nurse, Licensed – Nevada State Board of Nursing

PRESENTATIONS
Suprien, M. J. (2022, April 6–9). Parental education on human papillomavirus vaccination.
Western Institute of Nursing Conference, Portland, OR.
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